Professor Sir Bruce Ponder, Department of Oncology has been presented with a prestigious Lifetime Achievement Award by Cancer Research UK. The award recognises his contribution to the identification and understanding of genetic susceptibility to breast cancer and other common cancers, as well as his achievements in building cancer research in Cambridge into a world-renowned centre of excellence. To learn more about this research, please visit http://www.cambridgecancer.org.uk/research-groups/ponder-group
Dr Rosenfeld receiving his award
Also honoured was Dr Nitzan Rosenfeld, group leader at the Cancer Research UK Cambridge Institute, who was awarded the Future Leaders in Cancer Research Prize. Dr Rosenfeld’s group is working on developing a non-invasive blood test for cancer patients based on circulating tumour DNA which could help track how their tumours evolve and respond to treatment. The test could reduce the dependence on obtaining tumour biopsies, which are invasive and not possible in all clinical scenarios. Find out more by visiting http://www.rosenfeldlab.org/index.html
